Indications and uses
Temporarily protects and helps relieve chapped or cracked skin. Helps protect from the drying effects of wind and cold weather.
Dermasil Advanced
- Manufacturer
- Rise International Group LLC | Kingkey Daily Chemical Co., Ltd.
- Effective date
- 2014-01-13
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 7
- Source
- legacy-cache
- Hydrated at
- 2026-08-02 01:37:34
Label at a glance#
ProductDermasil Advanced
Active ingredientdimethicone
Label structure10 sections
Dosage and administration
Apply as needed
Contacts and useful links#
Websitewww.riseintlgroup.com
www.riseintlgroup.com
www.riseintlgroup.comLabel contents#
Full prescribing information#
SPL UNCLASSIFIED SECTION
Dermasil® Labs has developed Dermasil® OTC Advanced Treatment, a powerful extra-dry skin moisturizer and protectant. Enhanced with Vitamins E & B3, this nutrient-rich creamy lotion contains four systems to control and provide long-lasting relief from severe dry skin:
- Occlusives to block moisture loss from the skin's surface
- Humectant to bind water in the skin's outermost layers
- Skin Lipids to enhance the skin's natural ability to retain moisture
- EFA's an important component of the skin's moisture barrier
Indications:
Suitable for extra-dry skin, and control of symptoms such as chapping, cracking, flaking, roughness, redness, soreness, and the itching associated with dry skin.
Drug Facts
Active Ingredient
Dimethicone 1%
Purpose
Skin protectant
Uses
- Temporarily protects and helps relieve chapped or cracked skin.
- Helps protect from the drying effects of wind and cold weather.
Warnings
- For external use only.
- Do not get into eyes.
OTC - STOP USE SECTION
- Stop use and ask a doctor if : Condition worsens, Symptoms last more than 7 days or clear up and occur again within a few days.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
- Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
Directions
- Apply as needed
Inactive Ingredients
Water (Aqua), Petrolatum, Mineral OiL (Parraffinum Liquidum), Glycerin, Stearic Acid, Glycol Stearate, Glyceryl Stearate, PEG-40 Stearate, Cetyl Alcohol, Phenoxyethanol, Methylisothiazolinone, Iodopropynyl Butylcarbamate, Magnesium Aluminum Silicate, Fragrance, Helianthus Annuus (Sunflower) Seed Oil, Cetyl Acetate, Sodium Hydroxide, Acetylated Lanolin Alcohol, Carbomer, Disodium EDTA, Lecithin, Borago Officinalis Seed Oil, Cholesterol, Ascorbyl Palmitate, Prunus Amygdalus Dulcis (Sweet Almond) Oil, Ethylene Brassylate, Santalum Album (Sandalwood) Oil, Rosa Damascena Extract, Vanilla Planifolia Fruit Extract, Niacinamide, Inositol.
Questions/Comments? 1-800-282-1813
Please Recycle This Bottle.
www.riseintlgroup.com
RISE INTERNATIONAL GROUP LLC
Lodi, NJ 07644. Made in China
©RISE INTERNATIONAL GROUP LLC
Principal Display Panel - Bottle Label Dermasil 16oz
Dermasil®
LABS
Pharmaceutical Research
Controls Even Severe Dry Skin
Skin Lipid & EFA Treatment
Hypo-Allergenic
Dermasil
®
Advanced Treatment
CREAMY LOTION
16 FL.OZ. (1 PINT, 472 ml)
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 67143-0100-1 | 2024-11-18 | C162847 | 48780-1 | 9855e2a2-3330-60a7-e053-dbdaa90a05bd | 142ec9e6-30dc-4bff-b0c0-d3864c5c1e6f |
| 67143-0100-5 | 2024-11-18 | C162847 | 48780-1 | 9855e2a2-3330-60a7-e053-dbdaa90a05bd | 142ec9e6-30dc-4bff-b0c0-d3864c5c1e6f |
| 67143-0100-1 | 2019-11-27 | C162847 | 48780-1 | 9855e2a2-3330-60a7-e053-dbdaa90a05bd | 142ec9e6-30dc-4bff-b0c0-d3864c5c1e6f |
| 67143-0100-5 | 2019-11-27 | C162847 | 48780-1 | 9855e2a2-3330-60a7-e053-dbdaa90a05bd | 142ec9e6-30dc-4bff-b0c0-d3864c5c1e6f |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| dimethicone | ACTIVE INGREDIENT | 92RU3N3Y1O | 7 | |
| dimethicone | ACTIVE MOIETY | 92RU3N3Y1O | 7 | |
| ALMOND OIL | INACTIVE INGREDIENT | 66YXD4DKO9 | 7 | |
| ASCORBYL PALMITATE | INACTIVE INGREDIENT | QN83US2B0N | 7 | |
| BORAGE OIL | INACTIVE INGREDIENT | F8XAG1755S | 7 | |
| CARBOMER HOMOPOLYMER TYPE C | INACTIVE INGREDIENT | 4Q93RCW27E | 7 | |
| CETYL ALCOHOL | INACTIVE INGREDIENT | 936JST6JCN | 7 | |
| CETYL OLEATE | INACTIVE INGREDIENT | 78K2L26L8N | 7 | |
| CHOLESTEROL | INACTIVE INGREDIENT | 97C5T2UQ7J | 7 | |
| EDETATE DISODIUM | INACTIVE INGREDIENT | 7FLD91C86K | 7 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 7 | |
| GLYCERYL MONOSTEARATE | INACTIVE INGREDIENT | 230OU9XXE4 | 7 | |
| GLYCOL STEARATE | INACTIVE INGREDIENT | 0324G66D0E | 7 | |
| INOSITOL | INACTIVE INGREDIENT | 4L6452S749 | 7 | |
| IODOPROPYNYL BUTYLCARBAMATE | INACTIVE INGREDIENT | 603P14DHEB | 7 | |
| LANOLIN | INACTIVE INGREDIENT | 7EV65EAW6H | 7 | |
| LECITHIN, SOYBEAN | INACTIVE INGREDIENT | 1DI56QDM62 | 7 | |
| MAGNESIUM | INACTIVE INGREDIENT | I38ZP9992A | 7 | |
| METHYLISOTHIAZOLINONE | INACTIVE INGREDIENT | 229D0E1QFA | 7 | |
| MINERAL OIL | INACTIVE INGREDIENT | T5L8T28FGP | 7 | |
| NIACINAMIDE | INACTIVE INGREDIENT | 25X51I8RD4 | 7 | |
| PEG-40 STEARATE | INACTIVE INGREDIENT | ECU18C66Q7 | 7 | |
| PETROLATUM | INACTIVE INGREDIENT | 4T6H12BN9U | 7 | |
| PHENOXYETHANOL | INACTIVE INGREDIENT | HIE492ZZ3T | 7 | |
| ROSA DAMASCENA FLOWER | INACTIVE INGREDIENT | JWB78P295A | 7 | |
| SANDALWOOD OIL | INACTIVE INGREDIENT | X7X01WMQ5F | 7 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | 7 | |
| STEARIC ACID | INACTIVE INGREDIENT | 4ELV7Z65AP | 7 | |
| SUNFLOWER OIL | INACTIVE INGREDIENT | 3W1JG795YI | 7 | |
| VANILLA | INACTIVE INGREDIENT | Q74T35078H | 7 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 7 |
Products#
Every source-derived product name is available through these pages.
- Dermasil Advanced
- dimethicone
- WATER
- PETROLATUM
- MINERAL OIL
- GLYCERIN
- STEARIC ACID
- GLYCOL STEARATE
- GLYCERYL MONOSTEARATE
- SODIUM HYDROXIDE
- PEG-40 STEARATE
- CETYL ALCOHOL
- PHENOXYETHANOL
- MAGNESIUM
- IODOPROPYNYL BUTYLCARBAMATE
- SUNFLOWER OIL
- CETYL OLEATE
- LANOLIN
- CARBOMER HOMOPOLYMER TYPE C
- METHYLISOTHIAZOLINONE
- EDETATE DISODIUM
- LECITHIN, SOYBEAN
- BORAGE OIL
- CHOLESTEROL
- ASCORBYL PALMITATE
- ALMOND OIL
- SANDALWOOD OIL
- ROSA DAMASCENA FLOWER
- VANILLA
- NIACINAMIDE
- INOSITOL
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 67143-0100 | 67143-0100-1, 67143-0100-5 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / INTRAMUSCULAR | 176 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | LIQUID / INTRAVENOUS | 0.03 %w/v | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | LIQUID / INTRAVENOUS | ADJ PH | ||
| CHOLESTEROL | CHOLESTEROL | 97C5T2UQ7J | INJECTABLE, LIPOSOMAL / INTRAVENOUS | 437 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | CREAM / TOPICAL | 190 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SHAMPOO, SUSPENSION / TOPICAL | 1 %w/w | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 5.4 mg | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | TABLET, EXTENDED RELEASE / ORAL | 529 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | CAPSULE / VAGINAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / DENTAL | 15 %w/v | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SUSPENSION, EXTENDED RELEASE / ORAL | 40 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | SUPPOSITORY / RECTAL | NA | ||
| CETYL ALCOHOL | CETYL ALCOHOL | 936JST6JCN | SUSPENSION / OPHTHALMIC | 0.5 %w/v | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | TABLET, COATED / ORAL | 0.21 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION / SOFT TISSUE | 0.05 %w/v | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | AEROSOL, FOAM / TOPICAL | ADJ PH | ||
| PHENOXYETHANOL | PHENOXYETHANOL | HIE492ZZ3T | CREAM / TOPICAL | 57 mg | ||
| LANOLIN | LANOLIN | 7EV65EAW6H | CREAM / TOPICAL | 10 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / ORAL | 9120 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | FILM, SOLUBLE / BUCCAL | 5 mg | ||
| PHENOXYETHANOL | PHENOXYETHANOL | HIE492ZZ3T | GEL / TOPICAL | 14 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SPRAY, METERED / NASAL | ADJ PH | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | AEROSOL, FOAM / TOPICAL | 8 %w/w | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | OINTMENT / TOPICAL | 5 %w/w | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET, EXTENDED RELEASE / ORAL | 200 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | CAPSULE, COATED / ORAL | 0.08 mg | ||
| LANOLIN | LANOLIN | 7EV65EAW6H | EMULSION / TOPICAL | 0.25 %w/w | ||
| LECITHIN, SOYBEAN | SOYBEAN LECITHIN | 1DI56QDM62 | AEROSOL, METERED / RESPIRATORY (INHALATION) | 0.1 %w/w | ||
| ASCORBYL PALMITATE | ASCORBYL PALMITATE | QN83US2B0N | SOLUTION / TOPICAL | NA | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SUSPENSION / ORAL | 30 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | GEL / TOPICAL | 70 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | AEROSOL / TOPICAL | 3 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRADERMAL | 1.6 %w/v | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / TOPICAL | 39 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | SHAMPOO / TOPICAL | 9.7 %w/w | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION / INTRAVASCULAR | 0.48 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | TABLET, COATED / ORAL | 1.5 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | POWDER / INTRAVENOUS | ADJ PH | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | TABLET, CHEWABLE / ORAL | 1 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | LOTION, AUGMENTED / TOPICAL | ADJ PH | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / INTRADERMAL | ADJ PH | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAVENOUS | 33750 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / TOPICAL | 500 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / ORAL | 26208 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SYSTEM / TOPICAL | 18144 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION, SOLUTION / INTRAMUSCULAR | 4 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, CHEWABLE / ORAL | 12 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / INTRA-ARTICULAR | ADJ PH | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | EMULSION / TOPICAL | 7.8 %w/w | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SHAMPOO / TOPICAL | 3 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRACAVERNOUS | ADJ PH | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / INTRAMUSCULAR | ADJ PH | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | CONCENTRATE / ORAL | 10 mg/5ml | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | EMULSION / ORAL | ADJ PH | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | TABLET, CHEWABLE / ORAL | 1 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 120 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LIQUID / ORAL | 2400 mg | ||
| CETYL ALCOHOL | CETYL ALCOHOL | 936JST6JCN | AEROSOL, FOAM / TOPICAL | 82 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SUSPENSION/ DROPS / OPHTHALMIC | 1 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / INTRABURSAL | ADJ PH |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 97e3a851-bbaf-43b3-a319-c1bfc23a1b43 | 142ec9e6-30dc-4bff-b0c0-d3864c5c1e6f | 2024-11-15 | Warnings | 142ec9e6-30dc-4bff-b0c0-d3864c5c1e6f |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.